APOTHEMA LTD.

Company Registration Number:
11023360 (England and Wales)

Unaudited micro entity accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

APOTHEMA LTD.

Contents of the Financial Statements

for the Period Ended 31 December 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

APOTHEMA LTD.

Company Information

for the Period Ended 31 December 2024




Director: Miroslav Dopudja
Secretary: Miroslav Dopudja
Registered office: 73 Broadwalk Court
79 Palace Gardens Terrace
Kensington
London
England
W8 4EG
Company Registration Number: 11023360 (England and Wales)

APOTHEMA LTD.

Directors' Report Period Ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Directors

The directors shown below have held office during the whole of the period from 01 January 2024 to 31 December 2024
Miroslav Dopudja

Secretary
Miroslav Dopudja

This report was approved by the board of directors on 13 September 2025
And Signed On Behalf Of The Board By:

Name: Miroslav Dopudja
Status: Director

APOTHEMA LTD.

Profit and Loss Account

for the Period Ended 31 December 2024


2024
£

2023
£
Turnover 5,927 5,429
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 6,069 ) ( 5,589 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 142 ) ( 160 )

APOTHEMA LTD.

Balance sheet

As at 31 December 2024


2024
£

2023
£
Called up share capital not paid: 1,000 1,000
Fixed Assets: 0 0
Current assets: 566 317
Prepayments and accrued income: 0 391
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 566 708
Total assets less current liabilities: 1,566 1,708
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 1,566 1,708
Capital and reserves: 1,566 1,708

APOTHEMA LTD.

Balance sheet continued

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 13 September 2025
And Signed On Behalf Of The Board By:

Name: Miroslav Dopudja
Status: Director

The notes form part of these financial statements

APOTHEMA LTD.

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Employee Information

    Average number of employees: 0

APOTHEMA LTD.

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Off balance sheet disclosure

    No